Concepedia

Earl W. May

EW

Statistics

Publications

16

Citations

1.7K

H-Index

14

Active since

1995

Affiliations

GlaxoSmithKline (United States)(Current)

Bernstein Center for Computational Neuroscience Tübingen

Roswell Park Comprehensive Cancer Center

Johns Hopkins University

University at Buffalo, State University of New York

Earl W. May is an author at GlaxoSmithKline (United States) specializing in medicine, natural sciences, and drug discovery.

Top concepts

MedicineDrug DiscoveryNatural SciencesPharmacologyMolecular BiologyMedicinal ChemistryBiochemistryCell BiologyGeneticsMolecular Genetics

Publications per year

1995–2024

16

Publications

16

Type IIA topoisomerase inhibition by a new class of antibacterial agents

B.D. Bax, Pan F. Chan, Drake S. Eggleston et al. · Nature · 2010 · 803 citations

Antibacterial Agents, Medicinal Chemistry, Inhibitory Activity +14

Demonstration of a Genetic Therapeutic Index for Tumors Expressing Oncogenic <i>BRAF</i> by the Kinase Inhibitor SB-590885

Alastair J. King, Denis R. Patrick, Roberta S. Batorsky et al. · Cancer Research · 2006 · 262 citations · Full text

Pathology, Oncogenic Braf Alleles, Tumor Biology +17

The Tn7 transposase is a heteromeric complex in which DNA breakage and joining activities are distributed between different gene products.

Robert Sarnovsky, Earl W. May, Nancy L. Craig · The EMBO Journal · 1996 · 160 citations · Full text

Dna Sequencing, Dna Breakage, Genetics +6

Switching from Cut-and-Paste to Replicative Tn7 Transposition

Earl W. May, Nancy L. Craig · Science · 1996 · 137 citations

Unexpected Structural Diversity in DNA Recombination

Alison B. Hickman, Ying Li, Shiny Mathew et al. · Molecular Cell · 2000 · 130 citations · Full text

Unexpected Structural Diversity, Genetics, Genome Structure +6

1–5 of 16